2018
DOI: 10.21873/invivo.11333
|View full text |Cite
|
Sign up to set email alerts
|

Correlation Between Contrast-enhanced Ultrasound Characteristics (Qualitative and Quantitative) and Pathological Prognostic Factors in Breast Cancer

Abstract: CEUS has the potential to provide a prevision of pathological prognostic factors in malignant breast lesions, helping in the better early patient management.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
17
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 49 publications
0
17
0
Order By: Relevance
“…Controversial cases were reanalyzed and discussed until a unified conclusion was achieved. Characteristics of the lymph nodes shown in the CEUS image include (1) lesion's enhancement order: due to the different directions of contrast agent, enhancement order of lymph nodes includes centrifugal perfusion and centripetal perfusion; (2) internal lesion's homogeneity: according to whether the contrast agent filled the defect area within the lesion at the time of peak, internal lesion's homogeneity was divided into homogeneous enhancement and inhomogeneous enhancement; (3) lesion's enhancement degree: compared with adjacent tissues around the lymph node region at peak enhancement, the degree of nodal enhancement could be divided into hyperenhancement, hypoenhancement, and no enhancement; (4) presence of perfusion defects: whether there is a filling defect area after the injection of contrast agent (15).…”
Section: Ceus Examinationmentioning
confidence: 99%
“…Controversial cases were reanalyzed and discussed until a unified conclusion was achieved. Characteristics of the lymph nodes shown in the CEUS image include (1) lesion's enhancement order: due to the different directions of contrast agent, enhancement order of lymph nodes includes centrifugal perfusion and centripetal perfusion; (2) internal lesion's homogeneity: according to whether the contrast agent filled the defect area within the lesion at the time of peak, internal lesion's homogeneity was divided into homogeneous enhancement and inhomogeneous enhancement; (3) lesion's enhancement degree: compared with adjacent tissues around the lymph node region at peak enhancement, the degree of nodal enhancement could be divided into hyperenhancement, hypoenhancement, and no enhancement; (4) presence of perfusion defects: whether there is a filling defect area after the injection of contrast agent (15).…”
Section: Ceus Examinationmentioning
confidence: 99%
“…Compared to that of the surrounding thyroid tissue, the peak intensity of the nodule was classified into ( 1 ): hypo-enhancement ( 2 ), iso-enhancement ( 3 ), hyper-enhancement. According to the preceding studies ( 27 , 28 ), the presence of tumor-adjacent hyper-enhancement area(s) was indicative of high invasiveness of tumors. This feature was defined as the hyper-enhancement area(s) abutting on tumor.…”
Section: Methodsmentioning
confidence: 90%
“…According to the literature 2,3,8,10,12 and our clinical experience, indicators from B‐mode US and CEUS were defined as follows: (1) shape—regular (round or oval) or irregular; (2) orientation—parallel or not parallel; (3) margin—circumscribed or not circumscribed (indistinct, angular, microlobulated, or spiculated); (4) echo pattern—hypoechoic, isoechoic, hyperechoic, complex cystic and solid, or heterogeneous; (5) microcalcifications—present or absent; (6) posterior features—no posterior acoustic features, enhancement, shadowing, or a combined pattern; (7) vascularity—absent, internal vascularity, or vessels in the rim; (8) enhancement direction—centrifugal enhancement (enhancement originating from the center of the lesion and developing centrifugally), diffused enhancement, or centripetal enhancement (enhancement originating from the periphery of the lesion and developing centripetally); (9) enhancement intensity—hyperenhancement, hypoenhancement, or isoenhancement; (10) enhancement mode—homogeneous enhancement or heterogeneous enhancement; (11) enhancement scope—enlarged or not enlarged (compared with corresponding values measured by B‐mode US when both the length and width measured by CEUS were enlarged, or either was enlarged by ≥3 mm); (12) enhancement boundary—well defined (>50% of the lesion circumference clearly visible) or poorly defined (<50% of lesion circumference clearly visible); (13) enhancement shape—regular or irregular; (14) perfusion defect—absence or presence of a blood perfusion defect; (15) perforator vessels—absence or presence of penetrating vessels; and (16) enhancement time—rapidly, equally, or slowly (compared with surrounding normal breast tissue).…”
Section: Methodsmentioning
confidence: 99%
“…6 Using the characteristics of the blood flow distribution and microcirculation perfusion to improve the diagnostic accuracy of BI-RADS category 3 to 5 breast lesions is an important recent research topic. 5,[7][8][9][10] Qualitative and quantitative indicators have been studied for the application of CEUS in breast disease for decades, and their importance has been proven. [11][12][13] Studies show differences between benign and malignant breast lesions in CEUS characteristics.…”
mentioning
confidence: 99%
See 1 more Smart Citation